StockData
BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc. (BBIO) stock

BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 3/30
$78.01+1.21 (+1.58%)

Close on Nov 18, 2026Market cap $15.20BP/E –Yield –

BridgeBio Pharma net income

Net income is the profit left for shareholders after every expense, interest and tax.

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$56.71M–
Q3 FY2025Sep 30, 2025-$182.74M–

More BridgeBio Pharma figures

See a number that looks wrong?